191 related articles for article (PubMed ID: 18558355)
1. Natural and disease associated anti-myeloperoxidase (MPO) autoantibodies.
Guilpain P; Servettaz A; Batteux F; Guillevin L; Mouthon L
Autoimmun Rev; 2008 Jun; 7(6):421-5. PubMed ID: 18558355
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic effects of antimyeloperoxidase antibodies in patients with microscopic polyangiitis.
Guilpain P; Servettaz A; Goulvestre C; Barrieu S; Borderie D; Chéreau C; Kavian N; Pagnoux C; Guillevin L; Weill B; Mouthon L; Batteux F
Arthritis Rheum; 2007 Jul; 56(7):2455-63. PubMed ID: 17599755
[TBL] [Abstract][Full Text] [Related]
3. Anti-idiotype antibodies to anti-myeloperoxidase autoantibodies in patients with systemic vasculitis.
Jayne DR; Esnault VL; Lockwood CM
J Autoimmun; 1993 Apr; 6(2):221-6. PubMed ID: 8388692
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies.
Schreiber A; Xiao H; Falk RJ; Jennette JC
J Am Soc Nephrol; 2006 Dec; 17(12):3355-64. PubMed ID: 17108314
[TBL] [Abstract][Full Text] [Related]
5. IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis.
Liu LJ; Chen M; Yu F; Zhao MH; Wang HY
Nephrology (Carlton); 2008 Oct; 13(7):629-35. PubMed ID: 18775059
[TBL] [Abstract][Full Text] [Related]
6. Contribution of myeloperoxidase in vasculitis development.
Suzuki K; Okazaki T
Jpn J Infect Dis; 2004 Oct; 57(5):S2-3. PubMed ID: 15507759
[TBL] [Abstract][Full Text] [Related]
7. MPO-ANCA induces IL-17 production by activated neutrophils in vitro via classical complement pathway-dependent manner.
Hoshino A; Nagao T; Nagi-Miura N; Ohno N; Yasuhara M; Yamamoto K; Nakayama T; Suzuki K
J Autoimmun; 2008 Aug; 31(1):79-89. PubMed ID: 18501296
[TBL] [Abstract][Full Text] [Related]
8. Systemic injection of products of activated neutrophils and H2O2 in myeloperoxidase-immunized rats leads to necrotizing vasculitis in the lungs and gut.
Heeringa P; Foucher P; Klok PA; Huitema MG; Tervaert JW; Weening JJ; Kallenberg CG
Am J Pathol; 1997 Jul; 151(1):131-40. PubMed ID: 9212739
[TBL] [Abstract][Full Text] [Related]
9. The oxidation induced by antimyeloperoxidase antibodies triggers fibrosis in microscopic polyangiitis.
Guilpain P; Chéreau C; Goulvestre C; Servettaz A; Montani D; Tamas N; Pagnoux C; Hachulla E; Weill B; Guillevin L; Mouthon L; Batteux F
Eur Respir J; 2011 Jun; 37(6):1503-13. PubMed ID: 21071471
[TBL] [Abstract][Full Text] [Related]
10. The clinical features and pathology of vasculitis associated with anti-myeloperoxidase autoantibodies.
Jayne D
Jpn J Infect Dis; 2004 Oct; 57(5):S16-7. PubMed ID: 15507756
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of oxidation activity of myeloperoxidase (MPO) by propylthiouracil (PTU) and anti-MPO antibodies from patients with PTU-induced vasculitis.
Zhang AH; Chen M; Gao Y; Zhao MH; Wang HY
Clin Immunol; 2007 Feb; 122(2):187-93. PubMed ID: 17070108
[TBL] [Abstract][Full Text] [Related]
12. Endothelium myeloperoxidase-antimyeloperoxidase interaction in vasculitis.
Vargunam M; Adu D; Taylor CM; Michael J; Richards N; Neuberger J; Thompson RA
Nephrol Dial Transplant; 1992; 7(11):1077-81. PubMed ID: 1336132
[TBL] [Abstract][Full Text] [Related]
13. Enhanced monocyte generation of reactive oxygen species in primary systemic vasculitis.
Bruce I; McNally J; Bell A
J Rheumatol; 1997 Dec; 24(12):2364-70. PubMed ID: 9415643
[TBL] [Abstract][Full Text] [Related]
14. Follow-up of avidity and titer of anti-myeloperoxidase antibodies in sera from patients with primary ANCA-associated vasculitis.
Lin W; Chen M; Zhao MH
Autoimmunity; 2009 Mar; 42(3):198-202. PubMed ID: 19301200
[TBL] [Abstract][Full Text] [Related]
15. The influence of autoantibodies to myeloperoxidase on neutrophil function and intracellular signaling.
Williams J; Hewins P; Savage C
Jpn J Infect Dis; 2004 Oct; 57(5):S5-6. PubMed ID: 15507770
[TBL] [Abstract][Full Text] [Related]
16. Myeloperoxidase: friend and foe.
Klebanoff SJ
J Leukoc Biol; 2005 May; 77(5):598-625. PubMed ID: 15689384
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of Trypanosoma cruzi dihydrolipoamide dehydrogenase by leukocyte myeloperoxidase systems: role of hypochloride and nitrite related radicals.
Gutiérrez-Correa J; Krauth-Siegel RL; Stoppani AO
Rev Argent Microbiol; 2000; 32(3):136-43. PubMed ID: 11008705
[TBL] [Abstract][Full Text] [Related]
18. Oxidation of a metabolite of indomethacin (Desmethyldeschlorobenzoylindomethacin) to reactive intermediates by activated neutrophils, hypochlorous acid, and the myeloperoxidase system.
Ju C; Uetrecht JP
Drug Metab Dispos; 1998 Jul; 26(7):676-80. PubMed ID: 9660850
[TBL] [Abstract][Full Text] [Related]
19. Interaction between myeloperoxidase and antibodies against myeloperoxidase measured by chemiluminescence.
Nässberger L
J Biolumin Chemilumin; 1993; 8(1):33-7. PubMed ID: 8386428
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress induces myeloperoxidase expression in endocardial endothelial cells from patients with chronic heart failure.
La Rocca G; Di Stefano A; Eleuteri E; Anzalone R; Magno F; Corrao S; Loria T; Martorana A; Di Gangi C; Colombo M; Sansone F; Patanè F; Farina F; Rinaldi M; Cappello F; Giannuzzi P; Zummo G
Basic Res Cardiol; 2009 May; 104(3):307-20. PubMed ID: 19030913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
